USPTO trademark

SYNETS

RegisteredUSPTOWord and designClass 5

"SYNETS" is a word and design mark owned by Biogency Pty Ltd, filed at the USPTO on October 4, 2024. It is registered and covers class 5 (Pharmaceuticals).

View Biogency Pty Ltd portfolio Get this data via the API

Data current as of October 21, 2025Official USPTO record

As filed with the USPTO

Status: Registered; Since October 21, 2025
Filed: October 4, 2024
Registered: October 21, 2025
Priority date: September 20, 2024; Claimed from Australia
Application no.: 98785348
Registration no.: 7990192
Office: USPTO; United States Patent and Trademark Office
Mark type: Word and design; 1 class

Ownership

Who owns SYNETS

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Biogency Pty Ltd

Alexandra NSW, Australia

34 trademarks in the portfolioView company

Representative

Jennifer A. Visintine

Thompson Coburn LLP

Goods and services

What the mark covers

The products and services SYNETS is filed for, grouped by Nice class.

05Class 5 · Pharmaceuticals
Food supplements, namely, anti-oxidants; capsules sold empty for pharmaceutical purposes; capsules sold empty for veterinary pharmaceutical preparations; chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; collagen based medicated supplements for use as nutritional supplements; decoctions for pharmaceutical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; antioxidants in the nature of dietary supplements; dietary protein supplements; dietary supplements; dietary supplements for animals; dietary supplements with a cosmetic effect; effervescent pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; food supplements for medical purposes to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; herbal dietary supplements; dietary nutritional supplements; nutritional supplements; plant extracts, other than essential oils, being dietary supplements; medicated lozenges for pharmaceutical purposes; skin lotions for pharmaceutical purposes; pharmaceutical preparations to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations containing vitamins to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations for health care to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations for human use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations for oral use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical preparations for skin care; pharmaceutical preparations for veterinary use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; chemical products in the nature of chemical preparations for pharmaceutical use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; natural pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; pharmaceutical products to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; tablets being pharmaceuticals to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints; food supplements for animals in the nature of vitamins; vitamin supplements; dietary food supplements; nutritional drinks being dietary food supplements; food supplements in the nature of dietary supplements

History

What has happened so far

Steps recorded by the USPTO, newest first.

October 21, 2025Notice of registration confirmation emailed
October 21, 2025Registered-principal register
September 2, 2025Official gazette publication confirmation e-mailed
September 2, 2025Published for opposition
August 27, 2025Notification of notice of publication e-mailed
August 5, 2025Withdrawn from pub - og review query
July 1, 2025Approved for pub - principal register
May 27, 2025Teas/email correspondence entered
May 27, 2025Correspondence received in law office
May 27, 2025Teas response to office action received

7 earlier steps on the official record.

FAQ

About SYNETS

Who owns the trademark "SYNETS"?

The USPTO trademark "SYNETS" (application 98785348) is owned by Biogency Pty Ltd.

What is the status of "SYNETS"?

Its status at the USPTO is: registered.

When was "SYNETS" registered?

It was registered on October 21, 2025.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull SYNETS and marks like it into your own product with one request.

GET/v1/trademarks/{id}
The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/events
Every step in the office history
GET/v1/proceedings?trademark_id={id}
Oppositions and cancellations against the mark

Get API key View docs

GET /v1/trademarks/{id}

ID=tm_019d29ed-6d70-763c-be7d-e99e80132b09
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"

Response

{
  "id": "tm_019d29ed-6d70-763c-be7d-e99e80132b09",
  "object": "trademark",
  "mark_text": "SYNETS",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "98785348",
  "filing_date": "2024-10-04",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Biogency Pty Ltd",
      "entity_id": "ent_019eb7e7-eacb-75fe-a1ac-e8e88de68299"
    }
  ]
}